508 related articles for article (PubMed ID: 25387766)
21. Regulation of Notch signaling during T- and B-cell development by O-fucose glycans.
Stanley P; Guidos CJ
Immunol Rev; 2009 Jul; 230(1):201-15. PubMed ID: 19594638
[TBL] [Abstract][Full Text] [Related]
22. Induction of notch signaling by immobilization of jagged-1 on self-assembled monolayers.
Gonçalves RM; Martins MC; Almeida-Porada G; Barbosa MA
Biomaterials; 2009 Dec; 30(36):6879-87. PubMed ID: 19783294
[TBL] [Abstract][Full Text] [Related]
23. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
24. Notch signaling pathway in keloid disease: enhanced fibroblast activity in a Jagged-1 peptide-dependent manner in lesional vs. extralesional fibroblasts.
Syed F; Bayat A
Wound Repair Regen; 2012; 20(5):688-706. PubMed ID: 22985040
[TBL] [Abstract][Full Text] [Related]
25. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.
Patenaude A; Fuller M; Chang L; Wong F; Paliouras G; Shaw R; Kyle AH; Umlandt P; Baker JH; Diaz E; Tong J; Minchinton AI; Karsan A
Cancer Res; 2014 May; 74(9):2402-11. PubMed ID: 24599126
[TBL] [Abstract][Full Text] [Related]
26. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma.
Nickoloff BJ; Qin JZ; Chaturvedi V; Denning MF; Bonish B; Miele L
Cell Death Differ; 2002 Aug; 9(8):842-55. PubMed ID: 12107827
[TBL] [Abstract][Full Text] [Related]
27. Notch regulation of tumor angiogenesis.
Bridges E; Oon CE; Harris A
Future Oncol; 2011 Apr; 7(4):569-88. PubMed ID: 21463145
[TBL] [Abstract][Full Text] [Related]
28. Delta-like 4/Notch signaling and its therapeutic implications.
Yan M; Plowman GD
Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
[TBL] [Abstract][Full Text] [Related]
29. Notch ligands are biomarkers of anti-TNF response in RA patients.
Zack SR; Meyer A; Zanotti B; Volin MV; Deen S; Satoeya N; Sweiss N; Lewis MJ; Pitzalis C; Kitajewski JK; Shahrara S
Angiogenesis; 2024 May; 27(2):273-283. PubMed ID: 37796367
[TBL] [Abstract][Full Text] [Related]
30. Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.
Dos Santos SN; Sheldon H; Pereira JX; Paluch C; Bridges EM; El-Cheikh MC; Harris AL; Bernardes ES
Oncotarget; 2017 Jul; 8(30):49484-49501. PubMed ID: 28533486
[TBL] [Abstract][Full Text] [Related]
31. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
[TBL] [Abstract][Full Text] [Related]
32. MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo.
Jenkins DW; Ross S; Veldman-Jones M; Foltz IN; Clavette BC; Manchulenko K; Eberlein C; Kendrew J; Petteruti P; Cho S; Damschroder M; Peng L; Baker D; Smith NR; Weir HM; Blakey DC; Bedian V; Barry ST
Mol Cancer Ther; 2012 Aug; 11(8):1650-60. PubMed ID: 22679110
[TBL] [Abstract][Full Text] [Related]
33. Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.
Chen H; Liu D; Yang Z; Sun L; Deng Q; Yang S; Qian L; Guo L; Yu M; Hu M; Shi M; Guo N
Endocr Relat Cancer; 2014 Oct; 21(5):783-95. PubMed ID: 25179535
[TBL] [Abstract][Full Text] [Related]
34. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
Pagie S; Gérard N; Charreau B
Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
[TBL] [Abstract][Full Text] [Related]
35. CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells.
Mitra A; Shanthalingam S; Sherman HL; Singh K; Canakci M; Torres JA; Lawlor R; Ran Y; Golde TE; Miele L; Thayumanavan S; Minter LM; Osborne BA
Front Immunol; 2020; 11():735. PubMed ID: 32457739
[TBL] [Abstract][Full Text] [Related]
36. Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision.
Boareto M; Jolly MK; Ben-Jacob E; Onuchic JN
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3836-44. PubMed ID: 26153421
[TBL] [Abstract][Full Text] [Related]
37. Notch ligand delta-like1: X-ray crystal structure and binding affinity.
Kershaw NJ; Church NL; Griffin MD; Luo CS; Adams TE; Burgess AW
Biochem J; 2015 May; 468(1):159-66. PubMed ID: 25715738
[TBL] [Abstract][Full Text] [Related]
38. Delta-like ligand 4-notch blockade and tumor radiation response.
Liu SK; Bham SA; Fokas E; Beech J; Im J; Cho S; Harris AL; Muschel RJ
J Natl Cancer Inst; 2011 Dec; 103(23):1778-98. PubMed ID: 22010178
[TBL] [Abstract][Full Text] [Related]
39. Targeting specific regions of the Notch3 ligand-binding domain induces apoptosis and inhibits tumor growth in lung cancer.
Lin L; Mernaugh R; Yi F; Blum D; Carbone DP; Dang TP
Cancer Res; 2010 Jan; 70(2):632-8. PubMed ID: 20068176
[TBL] [Abstract][Full Text] [Related]
40. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth.
Xu Z; Wang Z; Jia X; Wang L; Chen Z; Wang S; Wang M; Zhang J; Wu M
Cancer Lett; 2016 Mar; 372(1):118-27. PubMed ID: 26739060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
